New hope for ALS patients: major drug trial aims to slow devastating disease
Disease control
Recruiting now
This Phase 3 trial is testing whether the drug pridopidine can slow the progression of ALS (amyotrophic lateral sclerosis) in adults. The study will involve 500 participants who will take either pridopidine or a placebo daily for 48 weeks, followed by another 48 weeks where every…
Phase: PHASE3 • Sponsor: Prilenia • Aim: Disease control
Last updated Mar 16, 2026 15:23 UTC